Symbols / ELAB $4.44 -8.26%
ELAB Chart
About
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 2.40M |
| Enterprise Value | -4.07M | Income | -6.49M | Sales | 285.95K |
| Book/sh | 273.83 | Cash/sh | 277.85 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 8.41 | P/B | 0.02 | P/C | — |
| EV/EBITDA | 0.70 | EV/Sales | -14.22 | Quick Ratio | 1.65 |
| Current Ratio | 1.79 | Debt/Eq | 51.93 | LT Debt/Eq | — |
| EPS (ttm) | -209.46 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -45.80% | Earnings | — | ROA | -27.98% |
| ROE | -76.20% | ROIC | — | Gross Margin | -82.03% |
| Oper. Margin | -7.52% | Profit Margin | 0.00% | Shs Outstand | 541.46K |
| Shs Float | 30.84K | Short Float | 2.67% | Short Ratio | 0.03 |
| Short Interest | — | 52W High | 688.00 | 52W Low | 3.97 |
| Beta | 1.13 | Avg Volume | 229.26K | Volume | 30.43K |
| Target Price | — | Recom | None | Prev Close | $4.84 |
| Price | $4.44 | Change | -8.26% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$4.44
Latest analyst target
3. DCF / Fair value
$-119.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.44
Low
—
High
—
Mean
—
- Why Did ELAB Stock Surge Nearly 8% After-Hours Today? - Stocktwits ue, 06 Jan 2026 08
- Own ELAB? 6 of your shares will turn into 1 on March 10 - Stock Titan Wed, 04 Mar 2026 08
- ELAB stock soars pre-market as PMGC subsidiary NorthStrive signs exclusive license agreement with Modulant Biosciences - MSN Sat, 07 Mar 2026 09
- PMGC Holdings Inc. Announces 1-for-6 Reverse Stock Split Effective March 10, 2026 - Quiver Quantitative Wed, 04 Mar 2026 08
- Market Movers | Winners: CAST, KIDZ, ELAB | Losers: ALUR, ARQ, CMCT - Trefis Wed, 11 Mar 2026 03
- PMGC Holdings Enters Fourth Secured Pre-Paid Equity Deal - The Globe and Mail Wed, 04 Mar 2026 08
- PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026 - GlobeNewswire Mon, 05 Jan 2026 08
- Top 3 Risk Off Stocks That could Lead To Your Biggest Gains This Quarter - Benzinga hu, 15 Jan 2026 08
- PMGC Holdings (NASDAQ: ELAB) enacts 1-for-6 reverse stock split on March 10, 2026 - Stock Titan ue, 10 Mar 2026 20
- PMGC Holdings Inc. Announces 1-for-4 Reverse Stock Split Effective January 6, 2026 - Quiver Quantitative ue, 06 Jan 2026 08
- ELAB Stock Soars Pre-Market As PMGC Subsidiary NorthStrive Signs Exclusive License Agreement With Modulant Biosciences - Stocktwits Wed, 11 Feb 2026 12
- New mouse study tests probiotic to protect muscle on GLP-1 treatment - Stock Titan ue, 10 Mar 2026 11
- PMGC buys Silicon Valley maker of parts for robots and satellites - Stock Titan ue, 03 Feb 2026 08
- Why one company is shrinking its share count with a 1-for-4 stock split - Stock Titan Fri, 02 Jan 2026 08
- This stock just cut its share count by 75% without changing value - Stock Titan Mon, 05 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -3.63M | -1.12M | -1.77M | -782.30K |
| TotalUnusualItems | 363.31K | -527.48K | -17.05K | 323.00 |
| TotalUnusualItemsExcludingGoodwill | 363.31K | -527.48K | -17.05K | 323.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -4.02M | -1.66M | -1.80M | -784.74K |
| ReconciledDepreciation | 12.95K | 11.65K | 6.51K | 2.76K |
| ReconciledCostOfRevenue | 576.66K | 317.49K | 88.00 | |
| EBITDA | -3.27M | -1.65M | -1.79M | -781.98K |
| EBIT | -3.28M | -1.66M | -1.80M | -784.74K |
| NetInterestIncome | -722.31K | 5.56K | 5.07K | 0.00 |
| InterestExpense | 735.20K | 0.00 | 2.63K | 0.00 |
| InterestIncome | 12.89K | 5.56K | 7.70K | 0.00 |
| NormalizedIncome | -4.38M | -1.13M | -1.78M | -785.06K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.25M | -4.30M | -1.80M | -784.74K |
| TotalExpenses | 3.66M | 1.13M | 2.55M | 785.89K |
| RentExpenseSupplemental | 126.10K | 73.36K | ||
| DilutedAverageShares | 5.68K | 884.00 | 884.00 | 884.00 |
| BasicAverageShares | 5.68K | 884.00 | 884.00 | 884.00 |
| DilutedEPS | -1.10K | -4.87K | -2.04K | -887.71 |
| BasicEPS | -1.10K | -4.87K | -2.04K | -887.71 |
| DilutedNIAvailtoComStockholders | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeCommonStockholders | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncome | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeIncludingNoncontrollingInterests | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeDiscontinuousOperations | -2.23M | -2.64M | ||
| NetIncomeContinuousOperations | -4.02M | -1.66M | -1.80M | -784.74K |
| PretaxIncome | -4.02M | -1.66M | -1.80M | -784.74K |
| OtherIncomeExpense | 363.31K | -527.48K | -17.05K | 323.00 |
| SpecialIncomeCharges | 0.00 | -450.08K | -1.55K | 0.00 |
| GainOnSaleOfPPE | 0.00 | -1.55K | 0.00 | |
| OtherSpecialCharges | 450.08K | |||
| GainOnSaleOfSecurity | 363.31K | -77.40K | -15.50K | 323.00 |
| NetNonOperatingInterestIncomeExpense | -722.31K | 5.56K | 5.07K | 0.00 |
| InterestExpenseNonOperating | 735.20K | 0.00 | 2.63K | 0.00 |
| InterestIncomeNonOperating | 12.89K | 5.56K | 7.70K | 0.00 |
| OperatingIncome | -3.66M | -1.13M | -1.79M | -785.06K |
| OperatingExpense | 3.66M | 1.13M | 2.24M | 785.80K |
| OtherOperatingExpenses | 236.91K | 110.39K | 272.44K | 25.45K |
| DepreciationAmortizationDepletionIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| DepreciationAndAmortizationInIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| DepreciationIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| ResearchAndDevelopment | 104.65K | 7.41K | 228.75K | 123.63K |
| SellingGeneralAndAdministration | 3.32M | 1.02M | 1.73M | 634.33K |
| SellingAndMarketingExpense | 292.52K | 256.45K | 192.86K | 31.61K |
| GeneralAndAdministrativeExpense | 3.02M | 760.02K | 1.54M | 602.73K |
| OtherGandA | 2.86M | 760.02K | 680.82K | 602.73K |
| RentAndLandingFees | 126.10K | 73.36K | ||
| SalariesAndWages | 165.00K | 1.86M | 782.33K | |
| GrossProfit | 1.13M | 447.31K | 739.00 | |
| CostOfRevenue | 578.01K | 318.97K | 88.00 | |
| TotalRevenue | 0.00 | 0.00 | 766.28K | 827.00 |
| OperatingRevenue | 0.00 | 0.00 | 766.28K | 827.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 31.36K | 884.00 | 884.00 | 884.00 |
| ShareIssued | 31.36K | 884.00 | 884.00 | 884.00 |
| TotalDebt | 210.49K | 283.22K | 0.00 | |
| TangibleBookValue | 3.86M | 3.83M | 1.13M | 450.24K |
| InvestedCapital | 6.66M | 3.83M | 1.13M | 450.24K |
| WorkingCapital | 4.25M | 3.62M | 963.05K | 420.90K |
| NetTangibleAssets | 3.86M | 3.83M | 1.13M | 450.63K |
| CapitalLeaseObligations | 210.49K | 283.22K | 0.00 | |
| CommonStockEquity | 6.66M | 3.83M | 1.13M | 450.24K |
| PreferredStockEquity | 571.00 | 385.00 | ||
| TotalCapitalization | 6.66M | 3.83M | 1.13M | 450.63K |
| TotalEquityGrossMinorityInterest | 6.66M | 3.83M | 1.13M | 450.63K |
| StockholdersEquity | 6.66M | 3.83M | 1.13M | 450.63K |
| GainsLossesNotAffectingRetainedEarnings | -337.00 | 202.00 | 111.00 | 202.00 |
| OtherEquityAdjustments | -337.00 | 202.00 | 111.00 | 202.00 |
| RetainedEarnings | -13.27M | -7.02M | -2.72M | -922.11K |
| AdditionalPaidInCapital | 19.93M | 10.85M | 3.85M | 1.37M |
| CapitalStock | 44.00 | 1.00 | 1.53K | 1.34K |
| CommonStock | 44.00 | 1.00 | 957.00 | 952.00 |
| PreferredStock | 0.00 | 571.00 | 385.00 | |
| TotalLiabilitiesNetMinorityInterest | 2.33M | 1.36M | 760.87K | 215.62K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 534.47K | 65.49K | 172.60K | 0.00 |
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 65.49K | ||
| TradeandOtherPayablesNonCurrent | 534.47K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 65.49K | 172.60K | 0.00 | |
| LongTermCapitalLeaseObligation | 65.49K | 172.60K | 0.00 | |
| CurrentLiabilities | 1.80M | 1.30M | 588.27K | 215.62K |
| OtherCurrentLiabilities | 548.92K | 1.09M | 68.45K | |
| CurrentDeferredLiabilities | 36.69K | 10.17K | 0.00 | |
| CurrentDeferredRevenue | 36.69K | 10.17K | 0.00 | |
| CurrentDebtAndCapitalLeaseObligation | 145.00K | 110.62K | ||
| CurrentCapitalLeaseObligation | 145.00K | 110.62K | 0.00 | |
| PayablesAndAccruedExpenses | 1.25M | 211.14K | 399.03K | 215.62K |
| CurrentAccruedExpenses | 73.23K | 33.86K | 93.93K | |
| Payables | 1.25M | 211.14K | 365.17K | 121.69K |
| OtherPayable | 350.00K | |||
| DuetoRelatedPartiesCurrent | 419.22K | 77.13K | 154.32K | 23.52K |
| AccountsPayable | 481.00K | 134.01K | 210.84K | 98.17K |
| TotalAssets | 8.99M | 5.19M | 1.89M | 666.25K |
| TotalNonCurrentAssets | 2.94M | 270.47K | 340.86K | 29.73K |
| OtherNonCurrentAssets | 268.73K | |||
| NonCurrentPrepaidAssets | 10.77K | 10.77K | ||
| InvestmentsAndAdvances | 139.08K | 0.00 | ||
| InvestmentinFinancialAssets | 139.08K | 0.00 | ||
| AvailableForSaleSecurities | 139.08K | |||
| TradingSecurities | 139.08K | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 2.80M | 0.00 | ||
| OtherIntangibleAssets | 2.80M | |||
| NetPPE | 1.09K | 1.74K | 330.09K | 29.73K |
| AccumulatedDepreciation | -1.51K | -1.08K | -8.11K | -2.76K |
| GrossPPE | 2.60K | 2.82K | 338.19K | 32.48K |
| OtherProperties | 259.76K | 327.07K | 32.48K | |
| MachineryFurnitureEquipment | 2.60K | 2.82K | 11.12K | 0.00 |
| CurrentAssets | 6.05M | 4.92M | 1.55M | 636.52K |
| AssetsHeldForSaleCurrent | 1.19M | 687.47K | ||
| PrepaidAssets | 868.46K | 902.05K | 153.42K | 62.14K |
| Inventory | 495.67K | 230.15K | 160.82K | |
| FinishedGoods | 68.25K | 32.03K | 48.68K | |
| WorkInProcess | 147.91K | 116.98K | 28.12K | |
| RawMaterials | 279.51K | 81.13K | 84.02K | |
| Receivables | 5.28K | 3.07K | 12.85K | 1.71K |
| TaxesReceivable | 5.28K | 3.07K | 8.67K | 1.71K |
| AccountsReceivable | 33.09K | 4.18K | 0.00 | |
| CashCashEquivalentsAndShortTermInvestments | 3.98M | 3.33M | 1.15M | 411.86K |
| CashAndCashEquivalents | 3.98M | 3.33M | 1.15M | 411.86K |
| CashFinancial | 3.98M | 3.33M | 1.15M | 411.86K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.96M | -4.57M | -1.62M | -693.42K |
| RepaymentOfDebt | -1.15M | 0.00 | ||
| IssuanceOfDebt | 914.44K | 0.00 | 183.97K | 0.00 |
| IssuanceOfCapitalStock | 6.99M | 6.70M | 2.15M | 1.09M |
| CapitalExpenditure | -471.48K | -11.19K | -35.53K | -32.48K |
| InterestPaidSupplementalData | 69.03K | 14.40K | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 3.98M | 3.33M | 1.15M | 411.86K |
| BeginningCashPosition | 3.33M | 1.15M | 411.86K | 13.35K |
| EffectOfExchangeRateChanges | -2.35K | 1.06K | -1.31K | 1.35K |
| ChangesInCash | 659.96K | 2.17M | 744.36K | 397.16K |
| FinancingCashFlow | 6.76M | 6.74M | 2.36M | 1.09M |
| CashFlowFromContinuingFinancingActivities | 6.76M | 6.74M | 2.36M | 1.09M |
| NetOtherFinancingCharges | -762.20K | |||
| ProceedsFromStockOptionExercised | 0.00 | 37.50K | 25.00K | 0.00 |
| NetPreferredStockIssuance | 0.00 | 2.15M | 1.09M | |
| PreferredStockIssuance | 0.00 | 2.15M | 1.09M | |
| NetCommonStockIssuance | 6.99M | 6.70M | 0.00 | |
| CommonStockIssuance | 6.99M | 6.70M | 0.00 | |
| NetIssuancePaymentsOfDebt | -235.56K | 0.00 | 183.97K | 0.00 |
| NetShortTermDebtIssuance | 0.00 | 183.97K | 0.00 | |
| ShortTermDebtIssuance | 0.00 | 183.97K | 0.00 | |
| NetLongTermDebtIssuance | -235.56K | 0.00 | ||
| LongTermDebtPayments | -1.15M | 0.00 | ||
| LongTermDebtIssuance | 914.44K | 0.00 | ||
| InvestingCashFlow | -610.56K | -11.19K | -32.03K | -32.48K |
| CashFlowFromContinuingInvestingActivities | -610.56K | -11.19K | -32.03K | -32.48K |
| NetInvestmentPurchaseAndSale | -139.08K | 0.00 | ||
| PurchaseOfInvestment | -139.08K | 0.00 | ||
| NetIntangiblesPurchaseAndSale | -462.32K | 0.00 | ||
| PurchaseOfIntangibles | -462.32K | 0.00 | ||
| NetPPEPurchaseAndSale | -9.16K | -11.19K | -32.03K | -32.48K |
| SaleOfPPE | 0.00 | 3.50K | ||
| PurchaseOfPPE | -9.16K | -11.19K | -35.53K | -32.48K |
| OperatingCashFlow | -5.49M | -4.56M | -1.59M | -660.93K |
| CashFlowFromContinuingOperatingActivities | -5.49M | -4.56M | -1.59M | -660.93K |
| ChangeInWorkingCapital | 251.67K | -823.19K | 12.43K | -21.91K |
| ChangeInOtherWorkingCapital | -2.39K | 26.52K | 10.17K | |
| ChangeInPayablesAndAccruedExpense | 605.23K | 346.37K | 185.19K | 199.10K |
| ChangeInPayable | 605.23K | 346.37K | 185.19K | 199.10K |
| ChangeInAccountPayable | 207.50K | 466.89K | 65.19K | 192.09K |
| ChangeInPrepaidAssets | 65.10K | -907.34K | -102.06K | -58.84K |
| ChangeInInventory | -403.30K | -265.52K | -69.33K | -160.82K |
| ChangeInReceivables | -12.97K | -23.22K | -11.55K | -1.35K |
| OtherNonCashItems | 766.13K | -2.76K | 9.28K | 600.00 |
| StockBasedCompensation | 97.17K | 487.74K | 171.87K | 142.35K |
| DepreciationAmortizationDepletion | 12.95K | 11.65K | 6.51K | 2.76K |
| DepreciationAndAmortization | 12.95K | 11.65K | 6.51K | 2.76K |
| Depreciation | 12.95K | 11.65K | 6.51K | 2.76K |
| OperatingGainsLosses | -369.16K | 71.27K | 14.30K | |
| GainLossOnInvestmentSecurities | -369.16K | 71.27K | 12.75K | |
| GainLossOnSaleOfPPE | 0.00 | 1.55K | 0.00 | |
| NetIncomeFromContinuingOperations | -6.25M | -4.30M | -1.80M | -784.74K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ELAB
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|